Skip to content

CAR T-CELL THERAPY: A ROAD MAP FOR NURSES

We apologize that you are experiencing technical difficulties with recording your participation in the September 10, 2020 ONS Bridge activity  on CAR T-Cell Therapy.  If you have already completed the evaluation and application for credit and received your certificate,  please disregard this request.  If not, please complete the form below to record your participation.  Please allow 1-2 weeks for certificate processing.
1.Enter your contact information(Required.)
2.RN License Number(Required.)
3.State of Licensure(Required.)
4.How long have you been  in practice?(Required.)
5.What is your  primary work setting/responsibility?(Required.)
6.Are you a member of a team that treats patients with CART therapy?(Required.)
7.To  what extent do you agree with the following statements about the faculty?(Required.)
Strongly Disagree
Disagree
Agree
Strongly Agree
Sherry Adkins, RN, MSN, CNS, ANP-C, was knowledgeable, effective, and clear in presenting the material
Heather DiFilippo, MSN, CRNP, was knowledgeable, effective, and clear in presenting the material
Ilene Galinsky, BSN, MSN, NP-C, was knowledgeable, effective, and clear in presenting the material
Kathleen McDermott, RN, BSN, OCN, BMTCN, was knowledgeable, effective, and clear in presenting the material
8.To  what extent do you agree with the following statements about the presentation?(Required.)
Strongly Disagree
Disagree
Agree
Strongly Agree
Content was accurate and timely
Course content was current
Information was appropriate to my education, experience, and licensure level
Information was suitable and useful to my daily practice
Information was free from commercial bias
9.To  what extent do you agree with the following statements about the materials, format, and technology?(Required.)
Strongly Disagree
Disagree
Agree
Strongly Agree
Materials were suitable and useful to the session topic
Format/course technology was effective overall
Instructions for asking questions/getting more information were provided
Location and/or technology and administration of the activity was appropriate to support participant learning
Technology was user-friendly
Technology was responsive
Course registration was user friendly
My questions or concerns were addressed effectively
My questions or concerns were addressed in a timely manner
The length of time to complete the course matches the number of CE credits awarded for this course
Overall presentation was effective
10.To  what extent do you agree with the following statements about the learning objectives?  After participating in this activity, I can...(Required.)
Strongly Disagree
Disagree
Agree
Strongly Agree
Provide an overview of chimeric antigen receptor (CAR) T-cell therapy and the blood cancers and solid tumors under study for treatment
Explain the nurse's role in assessment, monitoring for, and managing the effects of treatment
Describe the nurse's role in preparing patients and family members about the CART process and potential side effects of treatment
Address the need for communication with a patient's community oncologist and healthcare team to transition care after CAR T-cell therapy
11.Was there information you hoped to get from this program that you did not receive?(Required.)
12.Will you make changes that will benefit patient care as a result of information received in this activity?(Required.)
13.Please give us any additional feedback, including how we can improve the program and/or additional topics for future programs(Required.)
If you have additional questions following this program, please contact the Professional Education team at profeducation@lls.org
Upon submission, your participation will be recorded.  Your certificate will be emailed to you.  Please allow 1-2  weeks for processing.  Please email ndane@mlicme.org if you have any questions.
Privacy & Cookie Notice